The US FDA conducted an inspection at Orchid Pharma's Active Pharmaceutical Ingredient (API) manufacturing facility in Alathur, Tamil Nadu
At 02:40 PM; the BSE Smallcap and BSE Midcap indices were down 3.1% and 2.3%, respectively, as against 0.3% decline in the BSE Sensex.
The collaboration aims to tackle AMR in India by focusing on tier 2 and tier 3 cities, bridging the gap between awareness and action, and ensuring sustainable AMR interventions
The Earnings before interest, tax, depreciation, and amortisation (Ebitda) for the second quarter stood at Rs 30 crore as compared to Rs 24 crore a year ago which implies a rise of 25 per cent